Tragara Pharmaceuticals' Grant - II Round

Tragara Pharmaceuticals raised a round of funding on March 15, 2010. Investors include Multiple Myeloma Research Foundation.

Tragara Pharmaceuticals is a pharmaceutical company focused on the clinical and commercial development of drugs for the treatment of various cancers. TG02 is an orally available, small molecule that t…

Articles about Tragara Pharmaceuticals' Grant - II Round: